MAXCYTE, INC. Research And Development Expense

Quick Answer

MAXCYTE, INC. reported Research And Development Expense of $20.82 million for the year ending 2025.

  • MAXCYTE, INC. showed a decrease of -6.3% in Research And Development Expense from 2024 to 2025.
  • This data is from MAXCYTE, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), MAXCYTE, INC.'s Research And Development Expense has grown by 18.4%.
  • Historical annual values: Fiscal year 2025: $20.82 million | Fiscal year 2024: $22.23 million | Fiscal year 2023: $23.82 million | Fiscal year 2022: $19.51 million | Fiscal year 2021: $15.41 million | Fiscal year 2020: $17.73 million | Fiscal year 2019: $17.59 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: